Case report: Cerebral thromboembolism in an unconscious covid-19 patient in intensive care

ArticleAçık Erişim

Özet

Although the severity of coronavirus disease 2019 (COVID-19) being more frequently related to acute respiratory distress syndrome and acute cardiac and renal injuries, thromboembolic events have been increasingly reported. Acute respiratory distress syndrome due to SARS-CoV-2 (Severe Acute Respiratory Syndrome-Corona Virus 2) often requires intensive care follow-up. As well as respiratory failure, the SARS-CoV-2 may cause central nervous system (CNS) involvement. The pandemic has raised many challenges in managing critically ill older adults, a population preferentially killed by COVID-19. The mortality and morbidity rates are extremely high in critically ill patients with COVID-19. Recent studies have reported the potential development of a hypercoagulable state in COVID-19. Viral infections and hypoxia may cause these state. It is increasingly reported that thromboembolic events are associated with a poor prognosis. Due to these thromboembolic complications, COVID-19 patients often have neurological symptoms. These symptoms may not be observed in intensive care patients who are sedated. We report one case who was sedated COVID-19 pneumonia and who was later diagnosed with cerebral venous thrombosis with cranial imaging when he could not awaken even though sedation was discontinued. Since COVID-19 causes intense thrombotic susceptibility due to cytokine storm, cerebrovascular thromboembolic complications associated with COVID-19 infection should be considered first and foremost for unconsciousness ventilated patients. Severe and potentially cerebral thrombosis may prolong the patient´s stay in intensive care. © Edhem Unver et al.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13284Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorUnver, Edhem
dc.contributor.authorKuyrukluyildiz, Ufuk
dc.contributor.authorKaravas, Erdal
dc.contributor.authorTas, Hakan Gokalp
dc.date.accessioned2026-10-18T20:28:07.283766191Z
dc.date.available2026-10-18T20:28:07.283766191Z
dc.date.issued2021
dc.description.abstractAlthough the severity of coronavirus disease 2019 (COVID-19) being more frequently related to acute respiratory distress syndrome and acute cardiac and renal injuries, thromboembolic events have been increasingly reported. Acute respiratory distress syndrome due to SARS-CoV-2 (Severe Acute Respiratory Syndrome-Corona Virus 2) often requires intensive care follow-up. As well as respiratory failure, the SARS-CoV-2 may cause central nervous system (CNS) involvement. The pandemic has raised many challenges in managing critically ill older adults, a population preferentially killed by COVID-19. The mortality and morbidity rates are extremely high in critically ill patients with COVID-19. Recent studies have reported the potential development of a hypercoagulable state in COVID-19. Viral infections and hypoxia may cause these state. It is increasingly reported that thromboembolic events are associated with a poor prognosis. Due to these thromboembolic complications, COVID-19 patients often have neurological symptoms. These symptoms may not be observed in intensive care patients who are sedated. We report one case who was sedated COVID-19 pneumonia and who was later diagnosed with cerebral venous thrombosis with cranial imaging when he could not awaken even though sedation was discontinued. Since COVID-19 causes intense thrombotic susceptibility due to cytokine storm, cerebrovascular thromboembolic complications associated with COVID-19 infection should be considered first and foremost for unconsciousness ventilated patients. Severe and potentially cerebral thrombosis may prolong the patient´s stay in intensive care. © Edhem Unver et al.
dc.identifier.doi10.11604/pamj.2021.38.373.29034
dc.identifier.eissn1937-8688
dc.identifier.issn1937-8688
dc.identifier.pmcidPMC8309002
dc.identifier.pmid34367452
dc.identifier.scopus2-s2.0-85105717430
dc.identifier.startpage373
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13284
dc.identifier.volume38
dc.identifier.wosWOS:000653237800001
dc.language.isoen
dc.publisherAfrican Field Epidemiology Network
dc.relation.ispartofPan African Medical Journal
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCase report
dc.subjectCOVID-19
dc.subjectIntensive care
dc.subjectPneumonia
dc.subjectTromboembolia
dc.subjectCritical Care
dc.subjectDeep Sedation
dc.subjectHumans
dc.subjectIntracranial Thrombosis
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectazithromycin
dc.subjectC reactive protein
dc.subjectcreatine kinase
dc.subjectD dimer
dc.subjectenoxaparin
dc.subjectfavipiravir
dc.subjectferritin
dc.subjectfibrinogen
dc.subjecthydroxychloroquine
dc.subjectmethylprednisolone
dc.subjectmidazolam
dc.subjectoseltamivir
dc.subjectprocalcitonin
dc.subjectproton pump inhibitor
dc.subjectrocuronium
dc.subjecttocilizumab
dc.subjectadult
dc.subjectadult respiratory distress syndrome
dc.subjectArticle
dc.titleCase report: Cerebral thromboembolism in an unconscious covid-19 patient in intensive care
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus0
rdl.citation.wos0
rdl.departmentDepartment of Chest Disease, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey. | Department of Anesthesiology and Reanimation, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey. | Department of Radiology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexEmerging Sources Citation Index (ESCI)